Developer docs
API playgroundTry for free, no card

Search company profiles

Medovate

Full company profile

uuid0002ddz

Namestring
Medovate
Legal namestring
Medovate Limited
Websiteurl
medovate.co.uk
Company typeenum
Private
Founded yearint
2017
Short descriptiontext

Medovate is a Cambridge-based medical device developer spun out of the NHS in 2017 that commercialises clinician-originated innovations including the SAFIRA regional anaesthesia system, Glucosave, Humidicare, LUMEVAC, and CamPROBE, sold globally through exclusive regional distributors to hospitals and clinical practices.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMildenhall, United Kingdom
HQ citystring
Mildenhall
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical devices, regional anaesthesia, critical care safety, surgical devices, airway management
Industry1 code
PRIMARYHLAHADAJ
Anesthesia & Airway Management Equipment (Workstations, Laryngoscopy, Ventilation adjuncts)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
NAICS code3 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Medical Equipment and Supplies Manufacturing3391
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Medical Devices
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Device Sales
TypeHardware Sales
Description

Sale of proprietary medical devices including SAFIRA system, Glucosave, Humidicare, LUMEVAC, and CamPROBE. Revenue generated through direct sales and distributor partnerships across global markets.

medovate.co.uk
2Distribution Partnerships
TypeHardware Sales
Description

Revenue generated through exclusive and non-exclusive distribution agreements with regional partners across multiple territories including US, Europe, Middle East, Australia, and New Zealand.

medovate.co.uk
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels11 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1No public pricing tiers disclosed
ModelOtherBilling cadenceOther
Notes

Quote-based / Not publicly disclosed - requires contact with sales team or distributors for pricing information.

medovate.co.uk
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1SAFIRA®
Description

SAFer Injection for Regional Anaesthesia - a pioneering medical device that transforms regional anaesthesia into a single operator procedure with built-in safety mechanism to limit injection pressure.

medovate.co.uk
+4 more records
Core offering1 text field

Medovate develops and commercializes a portfolio of proprietary Class II medical devices invented by NHS clinicians, focused on patient safety in anaesthesia, airway management, critical care, and surgery. Its flagship product SAFIRA® transforms regional anaesthesia into a single-operator procedure with built-in automatic injection pressure limiting. Additional products include Glucosave® (insulin safety in critical care), Humidicare® (heat and moisture exchanger with dual humidification alerts), LUMEVAC™ (endoluminal vacuum therapy for GI leaks), and CamPROBE (transperineal prostate biopsy device), with a veterinary variant of SAFIRA also commercialized.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Automatic injection pressure limiting to below 20psi reduces nerve injury risk
+3 more records
Product overview1 text field

Medovate is a medical device development company that commercialises innovative technologies created within the NHS. The company offers a portfolio of medical devices focused on anaesthesia, airway management, critical care, and surgery. The core product portfolio includes SAFIRA® (regional anaesthesia system with pressure-limiting safety feature), CamPROBE (prostate biopsy device), Glucosave® (insulin safety device for critical care), Humidicare® (heat and moisture exchanger with dual humidification alert), and LUMEVAC™ (endoluminal vacuum therapy device for GI leaks). SAFIRA® is the company's flagship commercially launched product, while other products are at various stages of development and commercialisation. All devices are developed in collaboration with NHS clinicians to address unmet clinical needs and improve patient safety.

Product and service6 records
1SAFIRA®
CategoryRegional Anaesthesia Device
Description

Pioneering medical device that transforms regional anaesthesia into a single-operator procedure with a built-in safety mechanism that automatically limits injection pressure to reduce the risk of nerve injury. Consists of a proprietary syringe, driver, and foot pedal or palm operator.

2CamPROBE
CategoryUrology Diagnostic Device
Description

Safe, simple, and cost-effective solution intended to facilitate transperineal prostate biopsies under simultaneous local anaesthetic delivery.

3Glucosave®
CategoryCritical Care Safety Device
Description

Patient safety solution to help prevent inappropriate administration of insulin to patients in critical care settings.

4Humidicare®
CategoryAirway Management Device
Description

Novel heat and moisture exchanger (HME) that visually alerts clinicians to the presence of both active and passive humidification devices in mechanical breathing circuits, preventing potentially fatal airway occlusion from dual humidification errors.

5LUMEVAC™
CategorySurgical Device
Description

Pioneering endoscopic surgical device for endoluminal vacuum therapy (EVT) to help improve survival of patients with life-threatening infection following gastrointestinal tract leakage after procedures such as esophagectomy, enabling treatment without general anaesthesia.

6SAFIRA® for Veterinary Applications
CategoryVeterinary Regional Anaesthesia Device
Description

Application of SAFIRA regional anaesthesia technology for small animal veterinary practice, enabling single-operator procedures with automatic pressure limiting for nerve safety in orthopaedic and soft tissue procedures.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-listed medical device company with general surgery, endoscopic, and urology portfolios. Directly competes with LUMEVAC in endoscopic surgery and with CamPROBE in prostate biopsy.

TypeBroad incumbent
Description

Leading endoscopy and surgical device manufacturer. Competes with LUMEVAC in endoscopic GI therapeutic devices and adjacent endoscopy markets.

TypeDirect peer
Description

US-based medical device company with the REALTA endoluminal vacuum therapy system. Direct competitor to LUMEVAC in treating GI anastomotic leaks with EVT.

TypeBroad incumbent
Description

Global medical device manufacturer with a leading regional anesthesia portfolio (Perifix) and broad anesthesia/critical care offering. Directly competes with SAFIRA in regional anesthesia and competes in adjacent anesthesia/airway segments.

5Smiths Medical (ICU Medical)
TypeBroad incumbent
Description

Broad portfolio of anesthesia, airway management, and critical care devices. Competes with Medovate across regional anesthesia, HME/breathing circuits, and infusion safety categories.

TypeBroad incumbent
Description

Largest medical device company globally with broad anesthesia, surgical, and urology portfolios. Overlaps with Medovate in regional anesthesia, endoscopic surgery (LUMEVAC), and prostate biopsy (CamPROBE) categories.

TypeDirect peer
Description

European specialist in airway management, breathing circuits, and HME products. Directly competes with Humidicare in heat and moisture exchangers and dual humidification safety.

TypeDirect peer
Description

Germany-based specialist in regional anesthesia needles, catheters, and injection systems. Direct product overlap with SAFIRA in regional anesthesia nerve block procedures.

TypeEmerging player
Description

Global medical device company focused on anesthesia and neonatal products, and current Medovate distribution partner for SAFIRA across 60 countries. Sells its own regional anesthesia and anesthesia accessories, giving partial product overlap.

TypeDirect peer
Description

Major anesthesia and interventional device company with regional anesthesia and Arrow product lines. Directly competes with SAFIRA in regional anesthesia and overlaps with airway management products comparable to Humidicare.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Medovate

Medical Devicesmedovate.co.uk

Medovate is a Cambridge-based medical device developer spun out of the NHS in 2017 that commercialises clinician-originated innovations including the SAFIRA regional anaesthesia system, Glucosave, Humidicare, LUMEVAC, and CamPROBE, sold globally through exclusive regional distributors to hospitals and clinical practices.

Medovate firmographics

Firmographics
Name
Medovate
Legal name
Medovate Limited
Website
https://medovate.co.uk
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Medovate is a Cambridge-based medical device developer spun out of the NHS in 2017 that commercialises clinician-originated innovations including the SAFIRA regional anaesthesia system, Glucosave, Humidicare, LUMEVAC, and CamPROBE, sold globally through exclusive regional distributors to hospitals and clinical practices.
Ownership category
akta.pro rank

Medovate industry classification

Industry
Product category
Medical Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHADAJ
Anesthesia & Airway Management Equipment (Workstations, Laryngoscopy, Ventilation adjuncts)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment

Keywords

  • Medical devices
  • Regional anaesthesia
  • Critical care safety
  • Surgical devices
  • Airway management

Where Medovate is headquartered

Location

Headquarters

HQ city
Mildenhall
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Medovate business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Medical Device Sales: Sale of proprietary medical devices including SAFIRA system, Glucosave, Humidicare, LUMEVAC, and CamPROBE. Revenue generated through direct sales and distributor partnerships across global markets.
  2. Distribution Partnerships: Revenue generated through exclusive and non-exclusive distribution agreements with regional partners across multiple territories including US, Europe, Middle East, Australia, and New Zealand.

Pricing tiers

ModelBillingPrice
OtherOtherNo public pricing tiers disclosed

Go-to-market motion2 records

Distribution channels11 records

Marketing channels5 records

Medovate product offering

Product offering

Core offering

Medovate develops and commercializes a portfolio of proprietary Class II medical devices invented by NHS clinicians, focused on patient safety in anaesthesia, airway management, critical care, and surgery. Its flagship product SAFIRA® transforms regional anaesthesia into a single-operator procedure with built-in automatic injection pressure limiting. Additional products include Glucosave® (insulin safety in critical care), Humidicare® (heat and moisture exchanger with dual humidification alerts), LUMEVAC™ (endoluminal vacuum therapy for GI leaks), and CamPROBE (transperineal prostate biopsy device), with a veterinary variant of SAFIRA also commercialized.

Product overview

Medovate is a medical device development company that commercialises innovative technologies created within the NHS. The company offers a portfolio of medical devices focused on anaesthesia, airway management, critical care, and surgery. The core product portfolio includes SAFIRA® (regional anaesthesia system with pressure-limiting safety feature), CamPROBE (prostate biopsy device), Glucosave® (insulin safety device for critical care), Humidicare® (heat and moisture exchanger with dual humidification alert), and LUMEVAC™ (endoluminal vacuum therapy device for GI leaks). SAFIRA® is the company's flagship commercially launched product, while other products are at various stages of development and commercialisation. All devices are developed in collaboration with NHS clinicians to address unmet clinical needs and improve patient safety.

Differentiator

Problem solved

Functional benefit

Brands

  • SAFIRA®: SAFer Injection for Regional Anaesthesia - a pioneering medical device that transforms regional anaesthesia into a single operator procedure with built-in safety mechanism to limit injection pressure.
  • Glucosave®
  • Humidicare®
  • LUMEVAC™
  • CamPROBE

Products and services

  • SAFIRA® Pioneering medical device that transforms regional anaesthesia into a single-operator procedure with a built-in safety mechanism that automatically limits injection pressure to reduce the risk of nerve injury. Consists of a proprietary syringe, driver, and foot pedal or palm operator.
  • CamPROBE Safe, simple, and cost-effective solution intended to facilitate transperineal prostate biopsies under simultaneous local anaesthetic delivery.
  • Glucosave® Patient safety solution to help prevent inappropriate administration of insulin to patients in critical care settings.
  • Humidicare® Novel heat and moisture exchanger (HME) that visually alerts clinicians to the presence of both active and passive humidification devices in mechanical breathing circuits, preventing potentially fatal airway occlusion from dual humidification errors.
  • LUMEVAC™ Pioneering endoscopic surgical device for endoluminal vacuum therapy (EVT) to help improve survival of patients with life-threatening infection following gastrointestinal tract leakage after procedures such as esophagectomy, enabling treatment without general anaesthesia.
  • SAFIRA® for Veterinary Applications Application of SAFIRA regional anaesthesia technology for small animal veterinary practice, enabling single-operator procedures with automatic pressure limiting for nerve safety in orthopaedic and soft tissue procedures.

Quantifiable outcome

  • Automatic injection pressure limiting to below 20psi reduces nerve injury risk
  • +3 more outcomes

Companies that use Medovate

Customer profile

Named customers3 records

Segments6 records

Ideal customer profiles5 records

Medovate technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Medovate partnerships and signals

Strategic signal

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Medovate competitors and assessment

Company assessment

Direct peers

  • Conmed: US-listed medical device company with general surgery, endoscopic, and urology portfolios. Directly competes with LUMEVAC in endoscopic surgery and with CamPROBE in prostate biopsy.
  • Penumbra: US-based medical device company with the REALTA endoluminal vacuum therapy system. Direct competitor to LUMEVAC in treating GI anastomotic leaks with EVT.
  • Intersurgical: European specialist in airway management, breathing circuits, and HME products. Directly competes with Humidicare in heat and moisture exchangers and dual humidification safety.
  • Pajunk: Germany-based specialist in regional anesthesia needles, catheters, and injection systems. Direct product overlap with SAFIRA in regional anesthesia nerve block procedures.
  • Teleflex: Major anesthesia and interventional device company with regional anesthesia and Arrow product lines. Directly competes with SAFIRA in regional anesthesia and overlaps with airway management products comparable to Humidicare.

Broad incumbents

  • Olympus Medical: Leading endoscopy and surgical device manufacturer. Competes with LUMEVAC in endoscopic GI therapeutic devices and adjacent endoscopy markets.
  • B. Braun: Global medical device manufacturer with a leading regional anesthesia portfolio (Perifix) and broad anesthesia/critical care offering. Directly competes with SAFIRA in regional anesthesia and competes in adjacent anesthesia/airway segments.
  • Smiths Medical (ICU Medical): Broad portfolio of anesthesia, airway management, and critical care devices. Competes with Medovate across regional anesthesia, HME/breathing circuits, and infusion safety categories.
  • Medtronic: Largest medical device company globally with broad anesthesia, surgical, and urology portfolios. Overlaps with Medovate in regional anesthesia, endoscopic surgery (LUMEVAC), and prostate biopsy (CamPROBE) categories.

Emerging players

  • Vygon: Global medical device company focused on anesthesia and neonatal products, and current Medovate distribution partner for SAFIRA across 60 countries. Sells its own regional anesthesia and anesthesia accessories, giving partial product overlap.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Medovate social profiles

Digital presence

Medovate compliance and trust

Trust signal

Compliance3 records

Medovate financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Medovate leadership team

Management profile

Number of profiles

Profiles4 records

Medovate funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Medovate M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medovate

What does Medovate do?

Medovate develops and commercializes a portfolio of proprietary Class II medical devices invented by NHS clinicians, focused on patient safety in anaesthesia, airway management, critical care, and surgery. Its flagship product SAFIRA® transforms regional anaesthesia into a single-operator procedure with built-in automatic injection pressure limiting. Additional products include Glucosave® (insulin safety in critical care), Humidicare® (heat and moisture exchanger with dual humidification alerts), LUMEVAC™ (endoluminal vacuum therapy for GI leaks), and CamPROBE (transperineal prostate biopsy device), with a veterinary variant of SAFIRA also commercialized.

Is Medovate a public or private company?

Medovate is a private company. It is classified as venture growth investor backed and is currently operating.

When was Medovate founded?

Medovate was founded in 2017. It employs 11 to 50 people.

Where is Medovate based?

Medovate is headquartered in Mildenhall, United Kingdom, in the Europe region.

How does Medovate make money?

Two revenue lines are on record. Medical Device Sales are the primary driver. The others are distribution Partnerships.

Who are Medovate's main competitors?

Direct peers on record are Conmed, Penumbra, Intersurgical, Pajunk and Teleflex. Broad incumbents are Olympus Medical, B. Braun, Smiths Medical (ICU Medical) and Medtronic. Vygon is listed as an emerging player.

Does Medovate have an API?

No public API is recorded for Medovate.

What industry is Medovate in?

Medovate's product category is Medical Devices. Its primary akta.pro industry code is HLAHADAJ, Anesthesia & Airway Management Equipment (Workstations, Laryngoscopy, Ventilation adjuncts). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MedovateMedovate and JEB Technologies unite to form single medical device companyMedovate and JEB Technologies are merging into a single company under the Medovate name, combining their medical device operations. The combined entity will launch by September 21, 2026, with a new website. It plans new international product launches in 2027 and beyond, including regulatory approval for a device in the USA and Europe.EIN PresswireMedovate and JEB Technologies unite to form single medical device companyMedovate and JEB Technologies will merge under the Medovate name, combining operations and expertise. The combined company will launch by 21 September 2026, with products already in over 12 international markets. Plans include new international product launches in 2027 and beyond.Med-Tech InsightsItaly distribution deal for SAFIRA regional anaesthesia systemMedovate signed a distribution agreement with Coris Medica to make the SAFIRA regional anaesthesia system available to healthcare institutions across Italy. The system enables single-operator procedures and includes a safety mechanism that halts injection at a calibrated pressure threshold. The partnership aims to advance standards in anaesthesia care.BioSpaceMedovate Announces Exclusive US Distribution Agreement with Mercury Medical(R) for SAFIRA(R)Medovate announced an exclusive US distribution agreement with Mercury Medical for the FDA-cleared SAFIRA regional anesthesia device. The deal includes the SAFIRA Palm Operator and NRFit syringe, with Mercury Medical to distribute across the US. The company will showcase the device at the ASRA meeting in March 2022.QehklmediahubQEH wins Patient Safety Innovation of the Year AwardQEH won the Patient Safety Innovation of the Year Award at the Health Service Journal Awards 2021 for its SAFIRA device, which limits injection pressure during regional anaesthesia to prevent nerve injury. The device was developed with Medovate Ltd and aims to allow one-person techniques, with hopes of expanding access to safer regional anaesthesia.GlobeNewswireKonica Minolta, Medovate and Mercury Medical Collaborate on Ultrasound-guided Regional Anesthesia Education at ASRA 2021Konica Minolta, Medovate, and Mercury Medical will showcase their combined ultrasound-guided regional anesthesia solution at ASRA 2021 in Orlando. The solution pairs the SONIMAGE HS2 ultrasound system with SAFIRA, a device that limits injection pressure to 20psi to reduce nerve injury risk. The companies will also sponsor educational sessions and a clinical evaluation abstract.